publication venue for
- Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population.. 231. 2024
- Durable medication-free remission of sarcoidosis following discontinuation of anti-tumor necrosis factor-α therapy.. 206. 2022
- Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.. 205. 2022
- Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study.. 197. 2022
- Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.. 185. 2021
- Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.. 176. 2020
- A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.. 158. 2019
- Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis.. 152. 2019
- Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.. 140. 2018
- NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.. 140. 2018
- Sleep disturbance and symptom burden in sarcoidosis.. 144S. 2018
- Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients.. 131. 2017
- Frailty and maximal exercise capacity in adult lung transplant candidates.. 131. 2017
- Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial.. 131. 2017
- Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?. 122 Suppl 1. 2016
- A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD.. 120. 2016
- Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.. 118. 2016
- Hypersensitivity pneumonitis and antigen identification--An alternate approach.. 112. 2015
- Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.. 108. 2014
- Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.. 108. 2013
- The clinical impact of non-obstructive chronic bronchitis in current and former smokers.. 108. 2013
- One airway: Biomarkers of protection from upper and lower airway injury after World Trade Center exposure.. 108. 2013
- Genetic and environmental factors on the relation of lung function and arterial stiffness.. 107. 2013
- Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial.. 107. 2013
- Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.. 106. 2011
- Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD.. 105. 2011
- Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).. 104. 2010
- Gender influences Health-Related Quality of Life in IPF.. 104. 2009
- Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.. 103. 2008
- Does the relationship between asthma and obesity differ by neighborhood?. 102. 2008
- Slow-onset asthma deaths have more eosinophils and health care utilization than rapid-onset deaths.. 102. 2008
- A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly.. 102. 2008
- Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis.. 101. 2007
- Comparison of induced sputum inflammatory profiles between childhood and adult-onset asthma.. 100. 2006
- Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease.. 99. 2005
- Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction. 2017
- Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. 2010
- Moving towards a Treatable Traits model of care for the management of obstructive airways diseases. 2021
- Elevated serum cardiac troponin and mortality in acute pulmonary embolism: Systematic review and meta-analysis. 2019
- Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC. 2019